Valeant Pharma (VRX) Pays Down Additional $300M in Senior Secured Term Loans; Reduced Debt by More than $6.5B Since Q116
Tweet Send to a Friend
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) announced it has paid down an additional $300 million of its senior secured term ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE